Diabetes triggers a PARP1 mediated death pathway in the heart through participation of FoxO1

Journal of Molecular and Cellular Cardiology

Volumn 53, Issue 5, 2012, Pages 677-686

  Puthanveetil, Prasanth ^a   Zhang, Dahai ^a   Wang, Ying ^a   Wang, Fang ^a   Wan, Andrea ^a   Abrahani, Ashraf ^a   Rodrigues, Brian ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cell death; Diabetic cardiomyopathy; FoxO1; GAPDH; Insulin signaling; S nitrosylation

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE 3; CELL PROTEIN; DIAZOXIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE (NADP); NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLSERINE; PROTEIN SIAH1; STREPTOZOCIN; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CELL COMPARTMENTALIZATION; CELL DEATH; CELL NUCLEUS; CELL SURVIVAL; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME BINDING; HEART MUSCLE CELL; HYPERGLYCEMIA; MALE; NITROSATIVE STRESS; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; RAT; SIGNAL TRANSDUCTION; TISSUE PREPARATION; WISTAR RAT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; BLOOD GLUCOSE; CELL NUCLEUS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIAZOXIDE; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSE; HYPERGLYCEMIA; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; NERVE TISSUE PROTEINS; NITRIC OXIDE SYNTHASE TYPE II; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, WISTAR; REACTIVE NITROGEN SPECIES; STRESS, PHYSIOLOGICAL; TYROSINE;

ANIMALIA; RATTUS NORVEGICUS;

EID: 84867398874     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.08.013     Document Type: Article

References (49)

1. Roberts A.W., Clark A.L., Witte K.K. Review article: left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease-do we need to screen our patients?. Diab Vasc Dis Res 2009, 6:153-163.
2. Desai A., Fang J.C. Heart failure with preserved ejection fraction: hypertension, diabetes, obesity/sleep apnea, and hypertrophic and infiltrative cardiomyopathy. Heart Fail Clin 2008, 4:87-97.
3. Tang W.H., Young J.B. Cardiomyopathy and heart failure in diabetes. Endocrinol Metab Clin North Am 2001, 30:1031-1046.
4. Falcão-Pires I., Leite-Moreira A.F. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Fail Rev 2012, 17:325-344.
5. Fang Z.Y., Prins J.B., Marwick T.H. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004, 25:543-567.
6. Lebeche D., Davidoff A.J., Hajjar R.J. Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy. Nat Clin Pract Cardiovasc Med 2008, 5:715-724.
7. Kawase Y., Hajjar R.J. The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases. Nat Clin Pract Cardiovasc Med 2008, 5:554-565.
8. Goumans M.J., van Zonneveld A.J., ten Dijke P. Transforming growth factor beta-induced endothelial-to-mesenchymal transition: a switch to cardiac fibrosis?. Trends Cardiovasc Med 2008, 18:293-298.
9. Singh V.P., Le B., Khode R., Baker K.M., Kumar R. Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes 2008, 57:3297-3306.
10. An D., Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2006, 291:H1489-H1506.
11. Clarke M., Bennett M., Littlewood T. Cell death in the cardiovascular system. Heart 2007, 93:659-664.
12. Westermann D., Van Linthout S., Dhayat S., Dhayat N., Schmidt A., Noutsias M., et al. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol 2007, 102:500-507.
13. Puthanveetil P., Wang Y., Zhang D., Wang F., Kim M.S., Innis S., et al. Cardiac triglyceride accumulation following acute lipid excess occurs through activation of a FoxO1-iNOS-CD36 pathway. Free Radic Biol Med 2011, 51:352-363.
14. Liu Z., Cao W. p38 mitogen-activated protein kinase: a critical node linking insulin resistance and cardiovascular diseases in type 2 diabetes mellitus. Endocr Metab Immune Disord Drug Targets 2009, 9:38-46.
15. Riad A., Unger D., Du J., Westermann D., Mohr Z., Sobirey M., et al. Chronic inhibition of p38MAPK improves cardiac and endothelial function in experimental diabetes mellitus. Eur J Pharmacol 2007, 554:40-45.
16. Matsumoto M., Han S., Kitamura T., Accili D. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest 2006, 116:2464-2472.
17. Yuan Z., Lehtinen M.K., Merlo P., Villen J., Gygi S., Bonni A. Regulation of neuronal cell death by MST1-FOXO1 signaling. J Biol Chem 2009, 284:11285-11292.
18. Kajihara T., Jones M., Fusi L., Takano M., Feroze-Zaidi F., Pirianov G., et al. Differential expression of FOXO1 and FOXO3a confers resistance to oxidative cell death upon endometrial decidualization. Mol Endocrinol 2006, 20:2444-2455.
19. Gross D.N., Wan M., Birnbaum M.J. The role of FOXO in the regulation of metabolism. Curr Diab Rep 2009, 9:208-214.
20. Wrede C.E., Dickson L.M., Lingohr M.K., Briaud I., Rhodes C.J. Protein kinase B/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (INS-1). J Biol Chem 2002, 277:49676-49684.
21. Shen B., Chao L., Chao J. Pivotal role of JNK-dependent FOXO1 activation in downregulation of kallistatin expression by oxidative stress. Am J Physiol Heart Circ Physiol 2010, 298:H1048-H1054.
22. van der Vos K.E., Coffer P.J. FOXO-binding partners: it takes two to tango. Oncogene 2008, 27:2289-2299.
23. Puthanveetil P., Wang Y., Wang F., Kim M.S., Abrahani A., Rodrigues B. The increase in cardiac pyruvate dehydrogenase kinase-4 after short-term dexamethasone is controlled by an Akt-p38-forkhead box other factor-1 signaling axis. Endocrinology 2010, 151:2306-2318.
24. Kornberg M.D., Sen N., Hara M.R., Juluri K.R., Nguyen J.V., Snowman A.M., et al. GAPDH mediates nitrosylation of nuclear proteins. Nat Cell Biol 2010, 12:1094-1100.
25. Hara M.R., Agrawal N., Kim S.F., Cascio M.B., Fujimuro M., Ozeki Y., et al. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol 2005, 7:665-674.
26. Yego E.C., Mohr S. siah-1 Protein is necessary for high glucose-induced glyceraldehyde-3-phosphate dehydrogenase nuclear accumulation and cell death in Muller cells. J Biol Chem 2010, 285:3181-3190.
27. Madsen-Bouterse S., Mohammad G., Kowluru R.A. Glyceraldehyde-3-phosphate dehydrogenase in retinal microvasculature: implications for the development and progression of diabetic retinopathy. Invest Ophthalmol Vis Sci 2010, 51:1765-1772.
28. Tanaka J., Qiang L., Banks A.S., Welch C.L., Matsumoto M., Kitamura T., et al. Foxo1 links hyperglycemia to LDL oxidation and endothelial nitric oxide synthase dysfunction in vascular endothelial cells. Diabetes 2009, 58:2344-2354.
29. Tanaka H., Yokota H., Jover T., Cappuccio I., Calderone A., Simionescu M., et al. Ischemic preconditioning: neuronal survival in the face of caspase-3 activation. J Neurosci 2004, 24:2750-2759.
30. Kim Y.M., Talanian R.V., Billiar T.R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 1997, 272:31138-31148.
31. Wang Y., Dawson V.L., Dawson T.M. Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos. Exp Neurol 2009, 218:193-202.
32. Heeres J.T., Hergenrother P.J. Poly(ADP-ribose) makes a date with death. Curr Opin Chem Biol 2007, 11:644-653.
33. Cai L., Kang Y.J. Cell death and diabetic cardiomyopathy. Cardiovasc Toxicol 2003, 3:219-228.
34. Liu Y., Dentin R., Chen D., Hedrick S., Ravnskjaer K., Schenk S., et al. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 2008, 456:269-273.
35. Cheng Z., White M.F. Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models. Antioxid Redox Signal 2011, 14:649-661.
36. Sengupta A., Molkentin J.D., Yutzey K.E. FoxO transcription factors promote autophagy in cardiomyocytes. J Biol Chem 2009, 284:28319-28331.
37. Marfe G., Tafani M., Fiorito F., Pagnini U., Iovane G., De Martino L. Involvement of FOXO transcription factors, TRAIL-FasL/Fas, and sirtuin proteins family in canine coronavirus type II-induced apoptosis. PLoS One 2011, 6:e27313.
38. Yang Y., Zhao Y., Liao W., Yang J., Wu L., Zheng Z., et al. Acetylation of FoxO1 activates Bim expression to induce apoptosis in response to histone deacetylase inhibitor depsipeptide treatment. Neoplasia 2009, 11:313-324.
39. Umar S., van der Laarse A. Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart. Mol Cell Biochem 2010, 333:191-201.
40. Massion P.B., Pelat M., Belge C., Balligand J.L. Regulation of the mammalian heart function by nitric oxide. Comp Biochem Physiol A Mol Integr Physiol 2005, 142:144-150.
41. Cassina A.M., Hodara R., Souza J.M., Thomson L., Castro L., Ischiropoulos H., et al. Cytochrome c nitration by peroxynitrite. J Biol Chem 2000, 275:21409-21415.
42. Radi R., Peluffo G., Alvarez M.N., Naviliat M., Cayota A. Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 2001, 30:463-488.
43. Sirover M.A. New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells. J Cell Biochem 2005, 95:45-52.
44. Harada N., Yasunaga R., Higashimura Y., Yamaji R., Fujimoto K., Moss J., et al. Glyceraldehyde-3-phosphate dehydrogenase enhances transcriptional activity of androgen receptor in prostate cancer cells. J Biol Chem 2007, 282:22651-22661.
45. Colell A., Green D.R., Ricci J.E. Novel roles for GAPDH in cell death and carcinogenesis. Cell Death Differ 2009, 16:1573-1581.
46. Cai L., Li W., Wang G., Guo L., Jiang Y., Kang Y.J. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 2002, 51:1938-1948.
47. Rodrigues B., Cam M.C., McNeill J.H. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem 1998, 180:53-57.
48. Battiprolu P.K., Hojayev B., Jiang N., Wang Z.V., Luo X., Iglewski M., et al. Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice. J Clin Invest 2012, 122:1109-1118.
49. Ni Y.G., Berenji K., Wang N., Oh M., Sachan N., Dey A., et al. Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling. Circulation 2006, 114:1159-1168.